Division of Pediatric Allergy and Immunology, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Pediatr Pulmonol. 2022 Nov;57(11):2622-2628. doi: 10.1002/ppul.26073. Epub 2022 Jul 22.
Antibiotic allergy is a big problem that may affect the treatment and life quality of patients with cystic fibrosis (CF).
To evaluate predictive factors for confirmed antibiotic hypersensitivity in children with CF.
In this case-controlled study, we examined 15 patients with CF who had been confirmed with antibiotic allergy. Additionally, we included a control group of age- and gender-matched 45 CF patients with no antibiotic allergy. The diagnosis of antibiotic allergy was confirmed in the presence of a compatible history and a positive response in the drug skin test or provocation test. Multiple drug hypersensitivity was classified according to the temporal relationship of antibiotics: (i) distant, (ii) simultaneous, and (iii) sequential. The data were analyzed by conditional logistic regression.
β-lactam allergy was confirmed in eight patients (ceftazidime n = 5, piperacillin-tazobactam n = 3) and non-β-lactam allergy was confirmed in two patients (ciprofloxacin n = 1, azithromycin n = 1). Additionally, multiple drug hypersensitivity in five patients (distant n = 4, sequential n = 1), among whom two patients showed hypersensitivity against ceftazidime/piperacillin-tazobactam+ ciprofloxacin/levofloxacin, two patients showed hypersensitivity against ceftazidime+ ciprofloxacin n = 2, and one patient showed hypersensitivity against piperacillin-tazobactam+ amikacin+ trimethoprim-sulfamethoxazole. All patients (n = 13) with confirmed β-lactam allergy were meropenem tolerant. Multivariate analysis indicated that immediate reactions (, p < 0.001) and allergic evaluation in the first six months after the reaction (p = 0.036) were significant risk factors for the prediction of antibiotic hypersensitivity.
Beta-lactam antibiotic allergy is the most commonly confirmed drug allergy in children with CF. However, unlike normal children, ceftazidime and piperacillin-tazobactam account for the majority.
抗生素过敏是一个大问题,可能会影响囊性纤维化 (CF) 患者的治疗和生活质量。
评估 CF 儿童中确认的抗生素过敏的预测因素。
在这项病例对照研究中,我们检查了 15 名被确认为抗生素过敏的 CF 患者。此外,我们还包括了一个年龄和性别匹配的 45 名无抗生素过敏的 CF 患者对照组。抗生素过敏的诊断是在存在相容的病史和药物皮肤试验或激发试验阳性反应的情况下确认的。根据抗生素的时间关系,对多种药物过敏进行分类:(i)远隔,(ii)同时,和(iii)连续。数据通过条件逻辑回归进行分析。
8 名患者(头孢他啶 n = 5,哌拉西林他唑巴坦 n = 3)被确认为β-内酰胺过敏,2 名患者(环丙沙星 n = 1,阿奇霉素 n = 1)被确认为非β-内酰胺过敏。此外,5 名患者(远隔 n = 4,连续 n = 1)出现多种药物过敏,其中 2 名患者对头孢他啶/哌拉西林他唑巴坦+环丙沙星/左氧氟沙星过敏,2 名患者对头孢他啶+环丙沙星过敏 n = 2,1 名患者对哌拉西林他唑巴坦+阿米卡星+复方新诺明过敏。所有(n = 13)被确认为β-内酰胺过敏的患者对美罗培南均耐受。多变量分析表明,立即反应(,p < 0.001)和反应后前六个月的过敏评估(p = 0.036)是抗生素过敏预测的显著危险因素。
β-内酰胺类抗生素过敏是 CF 儿童最常见的药物过敏。然而,与正常儿童不同,头孢他啶和哌拉西林他唑巴坦占多数。